Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 9, Supplement A, 1982   [Index by Author] 


Down Preface
Down Contributors
Down Articles
Down Summary
Down Index


[Search ALL Issues]


Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Preface Back

Harold C. Nue and Richard Wise
Preface
J. Antimicrob. Chemother. 1982 9: iii; doi:10.1093/jac/9.suppl_A.iii [PDF] [Request Permissions]  

Contributors Back

Contributors
J. Antimicrob. Chemother. 1982 9: v-viii; doi:10.1093/jac/9.suppl_A.v [PDF] [Request Permissions]  

Articles Back

R. Wise and J. M. Andrews
Activity of mezlocillin against Gram-negative and Gram-positive organisms: Comparison with other penicillins
J. Antimicrob. Chemother. 1982 9: 1-9; doi:10.1093/jac/9.suppl_A.1 [Abstract] [PDF] [Request Permissions]  

Karl Metzger
Killing of azlocillin- and mezlocilin-induced filamentous forms of Pseudomonas aeruginosa by decreasing concentrations of penicillin
J. Antimicrob. Chemother. 1982 9: 11-14; doi:10.1093/jac/9.suppl_A.11 [Abstract] [PDF] [Request Permissions]  

Christine C. Sanders
Mezlocillin: a broad spectrum penicillin highly active against Gram-positve organisms and Haemophilus influenzae
J. Antimicrob. Chemother. 1982 9: 15-21; doi:10.1093/jac/9.suppl_A.15 [Abstract] [PDF] [Request Permissions]  

Harold C. Neu
The efficacy of mezlocillin in the therapy of bacteraemia
J. Antimicrob. Chemother. 1982 9: 23-30; doi:10.1093/jac/9.suppl_A.23 [Abstract] [PDF] [Request Permissions]  

Heinz Grimm
Bacteriological antagonism between acylureidopenicillins and cephalosporins
J. Antimicrob. Chemother. 1982 9: 31-34; doi:10.1093/jac/9.suppl_A.31 [PDF] [Request Permissions]  

Arthur L. Barry and Ronald N. Jones
A three category system for interpretation of disk tests for Pseudomonas-active penicillins and β-lactamase hydrolysis/inhibition studies
J. Antimicrob. Chemother. 1982 9: 35-45; doi:10.1093/jac/9.suppl_A.35 [Abstract] [PDF] [Request Permissions]  

Harold C. Standiford, Anne Francoise Viollier, Marcia Moody, Jean Klastersky, Beverly Tatem, and Stephen C. Schimpff
Antibiotic combinations against Gram-negative bacilli and Staphylococcus aureus in cancer patients: comparative in-vitro and in-vivo activity of cefoperazone and mezlocillin singly or combined together
J. Antimicrob. Chemother. 1982 9: 47-49; doi:10.1093/jac/9.suppl_A.47 [PDF] [Request Permissions]  

W. Michael Scheld, James P. Brodeur, and John M. Keeley
Evaluation of mezlocillin in discriminative animal models of infection
J. Antimicrob. Chemother. 1982 9: 51-64; doi:10.1093/jac/9.suppl_A.51 [Abstract] [PDF] [Request Permissions]  

Ursula Gundert-Remy, Dieter Förster, Peter Schacht, and Ellen Weber
Kinetics of mezlocillin in patients with biliary t-tube drainage
J. Antimicrob. Chemother. 1982 9: 65-75; doi:10.1093/jac/9.suppl_A.65 [Abstract] [PDF] [Request Permissions]  

George R. Aronoff
Mezlocillin elimination in patients with impaired renal function
J. Antimicrob. Chemother. 1982 9: 77-79; doi:10.1093/jac/9.suppl_A.77 [PDF] [Request Permissions]  

Antoinette Mangione, David M. Janicke, F. Douglas Boudinot, Robert M. Schultz, and William J. Jusko
Dose-dependent pharmacokinetics of mezlocillin in subjects with normal and impaired renal function
J. Antimicrob. Chemother. 1982 9: 81-85; doi:10.1093/jac/9.suppl_A.81 [Abstract] [PDF] [Request Permissions]  

Theodore C. Eickhoff
Nosocomial infections—1981
J. Antimicrob. Chemother. 1982 9: 87-92; doi:10.1093/jac/9.suppl_A.87 [Abstract] [PDF] [Request Permissions]  

Ethan Rubinstein, Manfred Green, Michaela Modan, Pnina Amit, Larry Bernstein, and Arye Rubinstein
The effects of nosocomial infections on the length and costs of hospital stay
J. Antimicrob. Chemother. 1982 9: 93-100; doi:10.1093/jac/9.suppl_A.93 [Abstract] [PDF] [Request Permissions]  

Harold C. Neu and Pornpen Labthavikul
Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam
J. Antimicrob. Chemother. 1982 9: 101-106; doi:10.1093/jac/9.suppl_A.101 [Abstract] [PDF] [Request Permissions]  

A. Scott Lea, David V. Feliciano, and Layne O. Gentry
Intra-abdominal infections—an update
J. Antimicrob. Chemother. 1982 9: 107-113; doi:10.1093/jac/9.suppl_A.107 [Abstract] [PDF] [Request Permissions]  

Haragopal Thadepalli, Bhavani Rao, Vinod K. Dhawan, and Vinh T. Bath
Evaluation of mezlocillin in aerobic and anaerobic infections
J. Antimicrob. Chemother. 1982 9: 115-119; doi:10.1093/jac/9.suppl_A.115 [Abstract] [PDF] [Request Permissions]  

Jacobo Sabbaj, Miguel Torres, and Rodolfo Estrada
Comparative clinical evaluation of mezlocillin and carbenicillin
J. Antimicrob. Chemother. 1982 9: 121-124; doi:10.1093/jac/9.suppl_A.121 [Abstract] [PDF] [Request Permissions]  

C. H. Ramirez-Ronda, J. Gutiérrez, and R. H. Bermúdez
Comparative effectiveness, safety and tolerance of mezlocillin and ticarcillin: A prospective randomized trial
J. Antimicrob. Chemother. 1982 9: 125-129; doi:10.1093/jac/9.suppl_A.125 [Abstract] [PDF] [Request Permissions]  

H. Wacha and E. B. Helm
Efficacy of antibiotics in bacteriobilia
J. Antimicrob. Chemother. 1982 9: 131-137; doi:10.1093/jac/9.suppl_A.131 [Abstract] [PDF] [Request Permissions]  

Anthony W. Chow
Antimicrobial therapy of gynaecological infections: an overview
J. Antimicrob. Chemother. 1982 9: 139-147; doi:10.1093/jac/9.suppl_A.139 [Abstract] [PDF] [Request Permissions]  

John R. Marshall, Anthony W. Chow, and Tania C. Sorrell
Effectiveness of mezlocillin in female genital tract infections
J. Antimicrob. Chemother. 1982 9: 149-158; doi:10.1093/jac/9.suppl_A.149 [Abstract] [PDF] [Request Permissions]  

Alfred N. Poindexter
Comparative studies of mezlocillin, carbenicillin and ampicillin in the treatment of acute pelvic infection
J. Antimicrob. Chemother. 1982 9: 159-161; doi:10.1093/jac/9.suppl_A.159 [Abstract] [PDF] [Request Permissions]  

Vincent T. Andriole
Advances in the treatment of urinary infections
J. Antimicrob. Chemother. 1982 9: 163-172; doi:10.1093/jac/9.suppl_A.163 [Abstract] [PDF] [Request Permissions]  

Clair E. Cox
Multi-institutional study of mezlocillin therapy of urinary tract infections
J. Antimicrob. Chemother. 1982 9: 173-177; doi:10.1093/jac/9.suppl_A.173 [Abstract] [PDF] [Request Permissions]  

Paul O. Madsen and Ole S. Nielsen
Treatment of complicated urinary tract infections with mezlocillin and ticarcillin, a comparative study
J. Antimicrob. Chemother. 1982 9: 179-181; doi:10.1093/jac/9.suppl_A.179 [Abstract] [PDF] [Request Permissions]  

Jack L. Lefrock and Abdolghader Molavi
Necrotizing skin and subcutaneous infections
J. Antimicrob. Chemother. 1982 9: 183-192; doi:10.1093/jac/9.suppl_A.183 [PDF] [Request Permissions]  

Robert J. Fass and Rodney K. Kusumi
Mezlocillin: treatment of skin and soft tissue infections
J. Antimicrob. Chemother. 1982 9: 193-197; doi:10.1093/jac/9.suppl_A.193 [Abstract] [PDF] [Request Permissions]  

J. L. LeFrock, A. Molavi, B. Carr, R. Schell, B. Smith, K. Rolston, and A. Lentnek
Comparative clinical evaluation of mezlocillin and cefoxitin
J. Antimicrob. Chemother. 1982 9: 199-203; doi:10.1093/jac/9.suppl_A.199 [Abstract] [PDF] [Request Permissions]  

F. Marc LaForce
Respiratory infections: major advances
J. Antimicrob. Chemother. 1982 9: 205-208; doi:10.1093/jac/9.suppl_A.205 [Abstract] [PDF] [Request Permissions]  

R. V. McCloskey, D. Killebrew, V. Tutlane, and J. Bentley
A randomized double blinded comparison of mezlocillin and ticarcillin for the treatment of respiratory infections
J. Antimicrob. Chemother. 1982 9: 209-213; doi:10.1093/jac/9.suppl_A.209 [Abstract] [PDF] [Request Permissions]  

James C. Wade
Principles of empiric antibiotic usage in febrile patients with granulocytopenia
J. Antimicrob. Chemother. 1982 9: 215-222; doi:10.1093/jac/9.suppl_A.215 [Abstract] [PDF] [Request Permissions]  

F. Meunier-Carpentier and J. Klastersky
Experience of mezlocillin in immunocompromised patients
J. Antimicrob. Chemother. 1982 9: 223-226; doi:10.1093/jac/9.suppl_A.223 [Abstract] [PDF] [Request Permissions]  

Pedro Leal del Rosal
Mezlocillin and ticarcillin in the treatment of patients with serious systemic infections
J. Antimicrob. Chemother. 1982 9: 227-228; doi:10.1093/jac/9.suppl_A.227 [PDF] [Request Permissions]  

Marco A. González
Comparison of the efficacy and safety of mezlocillin and ticarcillin in the treatment of patients with serious systemic infections
J. Antimicrob. Chemother. 1982 9: 229-230; doi:10.1093/jac/9.suppl_A.229 [PDF] [Request Permissions]  

John D. Nelson
Current problems in bacterial infections of newborns
J. Antimicrob. Chemother. 1982 9: 231-233; doi:10.1093/jac/9.suppl_A.231 [Abstract] [PDF] [Request Permissions]  

David W. Teele
Bacterial infections in infants—an update
J. Antimicrob. Chemother. 1982 9: 235-240; doi:10.1093/jac/9.suppl_A.235 [PDF] [Request Permissions]  

T. Rubio, F. Wirth, and E. Karotkin
Pharmacokinetic studies of mezlocillin in newborn infants
J. Antimicrob. Chemother. 1982 9: 241-244; doi:10.1093/jac/9.suppl_A.241 [Abstract] [PDF] [Request Permissions]  

Larry K. Pickering, William G. Kramer, Deborah A. Armes, Lawrence S. Frankel, Irene R. Townsend, and Steve Culbert
Clinical pharmacology and efficacy of mezlodillin in paediatric patients with malignancy
J. Antimicrob. Chemother. 1982 9: 245-250; doi:10.1093/jac/9.suppl_A.245 [Abstract] [PDF] [Request Permissions]  

Thomas Chiu, R. Donald Garrison, Fuad Fakhreddine, and Elia M. Ayoub
Mezlocillin in neonatal infections: evaluation of efficacy and toxicity
J. Antimicrob. Chemother. 1982 9: 251-255; doi:10.1093/jac/9.suppl_A.251 [Abstract] [PDF] [Request Permissions]  

L. Weingärtner
Clinical aspects of mezlocillin-therapy in childhood
J. Antimicrob. Chemother. 1982 9: 257-262; doi:10.1093/jac/9.suppl_A.257 [Abstract] [PDF] [Request Permissions]  

Hugo Trujillo, Alvaro Bustos-González, Luis Carlos Peláez, David Halpert, Gloria Mejía de R., Carmen Tulia Zapata, and Beatríz Taboada
Mezlocillin in infants and children: efficacy, safety and pharmacokinetics
J. Antimicrob. Chemother. 1982 9: 263-265; doi:10.1093/jac/9.suppl_A.263 [Abstract] [PDF] [Request Permissions]  

C. A. Konopka, G. Arcieri, and P. Schacht
Clinical experience with meziodilin in Europe—overview
J. Antimicrob. Chemother. 1982 9: 267-272; doi:10.1093/jac/9.suppl_A.267 [Abstract] [PDF] [Request Permissions]  

Michael F. Parry and Harold C. Neu
The safety and tolerance of mezlocillin
J. Antimicrob. Chemother. 1982 9: 273-280; doi:10.1093/jac/9.suppl_A.273 [Abstract] [PDF] [Request Permissions]  

W. Eugene Sanders, Jr.
Mezlocillin: role in management of infectious diseases
J. Antimicrob. Chemother. 1982 9: 281-287; doi:10.1093/jac/9.suppl_A.281 [Abstract] [PDF] [Request Permissions]  

B. Wiedemann
Summary of pre-clinical data: microbiology and pharmacokinetics
J. Antimicrob. Chemother. 1982 9: 289-290; doi:10.1093/jac/9.suppl_A.289 [PDF] [Request Permissions]  

Summary Back

Harold C. Neu
Summary
J. Antimicrob. Chemother. 1982 9: 291-293; doi:10.1093/jac/9.suppl_A.291 [PDF] [Request Permissions]  

Index Back

Index
J. Antimicrob. Chemother. 1982 9: 295-299; doi:10.1093/jac/9.suppl_A.295 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.